Teruhiko Yokoyama Selected Research

Teruhiko Yokoyama Research Topics

Disease

12	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/2012 - 01/2004
9	Urinary Incontinence 03/2015 - 02/2004
8	Lower Urinary Tract Symptoms 01/2020 - 01/2004
6	Overactive Urinary Bladder (Overactive Bladder) 01/2020 - 01/2008
4	Prostatic Neoplasms (Prostate Cancer) 03/2012 - 01/2005
3	Ejaculatory Dysfunction 06/2015 - 10/2008
3	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2008 - 11/2003
2	Pain (Aches) 01/2020 - 01/2012
2	Spinal Cord Injuries (Spinal Cord Injury) 03/2015 - 03/2012
2	Nocturia 12/2008 - 02/2004
2	Hypertrophy 12/2006 - 11/2003
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Cystitis 08/2021
1	Hypercholesterolemia 05/2014
1	Urinary Retention 05/2014
1	Underactive Urinary Bladder 05/2014
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 03/2012
1	Multiple Sclerosis 03/2012
1	Residual Neoplasm 03/2012
1	Trigeminal Nerve Diseases (Trigeminal Nerve Disorders) 01/2012
1	Erectile Dysfunction 03/2011
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2006
1	Neoplasms (Cancer) 01/2006
1	Disease Progression 10/2005
1	Urge Urinary Incontinence (Urge Incontinence) 08/2004
1	Stress Urinary Incontinence 08/2004
1	Diabetic Neuropathies (Diabetic Neuropathy) 09/2002
1	Diabetes Mellitus 09/2002

Drug/Important Bio-Agent (IBA)

5	Type A Botulinum Toxins (Botox)FDA Link 03/2015 - 08/2009
4	Pharmaceutical PreparationsIBA 08/2021 - 02/2004
3	Cholinergic Antagonists (Anticholinergics)IBA 03/2015 - 02/2004
3	NeurotoxinsIBA 01/2012 - 10/2007
2	mirabegronIBA 01/2020 - 10/2019
2	Solifenacin Succinate FDA Link 10/2019 - 01/2013
2	Muscarinic AntagonistsIBA 01/2013 - 01/2009
2	silodosin FDA Link 01/2012 - 10/2008
2	naftopidilIBA 01/2009 - 07/2006
2	loxoprofen (CS 600)IBA 12/2008 - 02/2004
2	Nerve Growth Factor (NGF)IBA 01/2008 - 09/2002
2	Hormones (Hormone)IBA 02/2006 - 02/2004
1	Tadalafil (Cialis)FDA Link 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2014
1	imidafenacinIBA 01/2013
1	Therapeutic UsesIBA 03/2012
1	Cholinergic Agents (Cholinergics)IBA 03/2012
1	Tamsulosin (Flomax)FDA LinkGeneric 01/2012
1	incobotulinumtoxinA FDA Link 01/2012
1	FM 4-64IBA 01/2012
1	Adrenergic Receptors (Adrenergic Receptor)IBA 03/2011
1	propiverineIBA 01/2009
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2006
1	Estramustine FDA Link 02/2006
1	Phosphates (Orthophosphate)IBA 02/2006
1	Ifosfamide FDA LinkGeneric 02/2006
1	Cisplatin (Platino)FDA LinkGeneric 02/2006
1	Proteins (Proteins, Gene)FDA Link 01/2006
1	Prostate-Specific Antigen (Semenogelase)IBA 10/2005
1	SodiumIBA 02/2004
1	Hypnotics and Sedatives (Sedatives)IBA 02/2004
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 02/2004
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2004
1	urapidilIBA 01/2004
1	Tacrolimus (Prograf)FDA LinkGeneric 11/2003
1	CalcineurinIBA 11/2003
1	Acetic Acid (Vinegar)FDA LinkGeneric 09/2002
1	Streptozocin (Streptozotocin)FDA Link 09/2002

Therapy/Procedure

9	Therapeutics 01/2020 - 01/2004
2	Drug Therapy (Chemotherapy) 01/2022 - 02/2004
2	Prostatectomy (Retropubic Prostatectomy) 01/2005 - 02/2004
1	Withholding Treatment 03/2015
1	Radiotherapy 03/2012
1	Brachytherapy 03/2012
1	Intradermal Injections 01/2012
1	Nephrectomy 10/2011
1	Combination Drug Therapy (Combination Chemotherapy) 02/2006
1	Transurethral Resection of Prostate (TURP) 06/2004
1	Aftercare (After-Treatment) 02/2004